Cervical Cancer Research Paper - Paper Masters.
Cervical cancer screening by cytology (Pap testing) alone, Pap and HPV co-testing, or primary HPV testing may detect pre-invasive disease. Patients are commonly asymptomatic at presentation, and identified following screening. Patients with advanced disease may present with symptoms such as abnormal vaginal bleeding, postcoital bleeding, vaginal discharge, pelvic or back pain, dyspareunia, or.
Cervical cancer kills 260,000 women annually, and nearly 85% of these deaths occur in developing nations, where it is the leading cause of cancer deaths in women. Disparities of health and poverty play a large role in this high mortality rate. Whereas routine Papanicolaou and human papillomavirus (HPV) testing has dramatically reduced cervical cancer deaths in Western nations, without proper.
Excerpt from Research Paper: Cervical Cancer What it is Cervical cancer is cancer of the cervix. Cancer begins when a body's cells start growing and multiplying out of control. Any cells within a body can become cancerous with potential to spread to other parts of the body. Originating in the lining of the cervix or the womb, another name for.
Introduction. Cervical cancer is one of the most common cancers worldwide. In India, it is one the leading causes of mortality among women accounting for 23.3% of all cancer deaths.() India accounts for about 20% of cervical cancer cases reported from the world.() More than three-fourth of these patients are diagnosed in advanced stages leading to poor prospects of long term survival and cure.().
The following is noteworthy research in chemotherapy for cervical cancer. Neoadjuvant chemotherapy is given before the main treatment for cancer. Researchers are studying neoadjuvant chemotherapy in women with stage 1B2 to 3B cervical cancer (also called locally advanced cervical cancer) to see if it can help shrink the tumour so it is easier to remove with surgery. Giving chemotherapy before.
Papillomavirus Research aims to publish top quality articles, describing innovative research advances in the field of human tumour virology, including Epstein Barr virus (EBV), Human T cell leukemia virus (HTLV), Polyoma virus (PyV), Merkel Cell PolyomaVirus (MCPyV), Kaposi's Sarcoma Herpes Virus (KSHV) and Papillomaviruses (PV), as well as other related animal tumour virus models.
A human papillomavirus (HPV)-related malignancy, preventable by HPV vaccination, screening, and treatment of high-grade dysplasia. Cervical cancer screening by cytology (Pap testing) alone, Pap and HPV co-testing, or primary HPV testing may detect pre-invasive disease. Patients are commonly asymp.